Daniela Regazzo

1.1k total citations
36 papers, 765 citations indexed

About

Daniela Regazzo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Daniela Regazzo has authored 36 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Daniela Regazzo's work include Pituitary Gland Disorders and Treatments (22 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Adrenal and Paraganglionic Tumors (10 papers). Daniela Regazzo is often cited by papers focused on Pituitary Gland Disorders and Treatments (22 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Adrenal and Paraganglionic Tumors (10 papers). Daniela Regazzo collaborates with scholars based in Italy, Germany and France. Daniela Regazzo's co-authors include Carla Scaroni, Filippo Ceccato, Gianluca Occhi, Nora Albiger, Gianfranco Gabai, Daniel Mollé, Joëlle Léonil, Daniel Tomé, Rachel Boutrou and Didier Dupont and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Daniela Regazzo

35 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Regazzo Italy 17 464 259 243 145 97 36 765
Lance Kates France 7 140 0.3× 201 0.8× 328 1.3× 147 1.0× 23 0.2× 7 669
Fabio Arturo Grieco Italy 17 272 0.6× 596 2.3× 404 1.7× 124 0.9× 17 0.2× 23 1.2k
Luisa García-Haro Spain 7 58 0.1× 91 0.4× 335 1.4× 142 1.0× 16 0.2× 8 539
Jason S. Seidman United States 11 89 0.2× 177 0.7× 246 1.0× 166 1.1× 24 0.2× 17 680
Samuel Wyllie United States 8 101 0.2× 306 1.2× 129 0.5× 56 0.4× 45 0.5× 11 578
Manasvi S. Shah United States 14 173 0.4× 198 0.8× 444 1.8× 20 0.1× 24 0.2× 21 807
Lijun Dai China 13 76 0.2× 101 0.4× 153 0.6× 78 0.5× 6 0.1× 30 470
A. Chevalier France 11 107 0.2× 78 0.3× 82 0.3× 43 0.3× 57 0.6× 23 395
R. Mark Meloche Canada 15 187 0.4× 476 1.8× 194 0.8× 62 0.4× 15 0.2× 21 685
Minglan Yang China 11 79 0.2× 126 0.5× 132 0.5× 33 0.2× 32 0.3× 21 414

Countries citing papers authored by Daniela Regazzo

Since Specialization
Citations

This map shows the geographic impact of Daniela Regazzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Regazzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Regazzo more than expected).

Fields of papers citing papers by Daniela Regazzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Regazzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Regazzo. The network helps show where Daniela Regazzo may publish in the future.

Co-authorship network of co-authors of Daniela Regazzo

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Regazzo. A scholar is included among the top collaborators of Daniela Regazzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Regazzo. Daniela Regazzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pallafacchina, Giorgia, et al.. (2025). GIPR in GH-PitNETs: molecular and functional insights. Endocrine Related Cancer. 32(10).
2.
Bertozzi, Irene, et al.. (2024). Coexistence of multiple gene variants in some patients with erythrocytoses. Mediterranean Journal of Hematology and Infectious Diseases. 16(1). e2024021–e2024021. 2 indexed citations
3.
Vazza, Giovanni, Daniela Regazzo, Luca Denaro, et al.. (2023). The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas. International Journal of Molecular Sciences. 24(11). 9264–9264. 3 indexed citations
4.
Bertozzi, Irene, et al.. (2023). Targeted NGS analysis reveals a complex genetic background of idiopathic erythrocytosis in a large Venetian family. Genes & Diseases. 11(2). 561–563. 2 indexed citations
5.
Voltan, Giacomo, et al.. (2023). Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas. International Journal of Molecular Sciences. 24(12). 9920–9920. 5 indexed citations
6.
Casonato, Alessandra, et al.. (2023). No von Willebrand factor domains other than A1 are involved in type 2B von Willebrand disease: what the p.R924Q and p.A2178S variants teach us. Research and Practice in Thrombosis and Haemostasis. 7(6). 102200–102200. 2 indexed citations
7.
Ceccato, Filippo, Giacomo Voltan, Giorgia Antonelli, et al.. (2023). Paradoxical GH increase after oral glucose load in subjects with and without acromegaly. Journal of Endocrinological Investigation. 47(1). 213–221. 2 indexed citations
8.
Barbot, Mattia, Daniela Regazzo, Marialuisa Zilio, et al.. (2020). Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis. Pituitary. 23(5). 534–542. 8 indexed citations
9.
Ceccato, Filippo, Mattia Barbot, Elisa Selmin, et al.. (2020). Clinical presentation and management of acromegaly in elderly patients. HORMONES. 20(1). 143–150. 11 indexed citations
10.
Lombardi, Giuseppe, Mattia Barbot, Filippo Ceccato, et al.. (2020). Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature. Pituitary. 23(4). 359–366. 25 indexed citations
11.
Ferrari, Silvia, Daniela Regazzo, Carla Scaroni, et al.. (2020). A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome. Aging Clinical and Experimental Research. 33(7). 1987–1992. 1 indexed citations
12.
Regazzo, Daniela, Mattia Barbot, Carla Scaroni, Nora Albiger, & Gianluca Occhi. (2020). The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes. Reviews in Endocrine and Metabolic Disorders. 21(1). 165–183. 24 indexed citations
13.
Albiger, Nora, Daniela Regazzo, Maurizio Iacobone, & Carla Scaroni. (2019). Different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia. PubMed. 44(2). 205–220. 2 indexed citations
14.
Ceccato, Filippo, Mattia Barbot, Nora Albiger, et al.. (2017). Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma. Endocrine. 59(3). 510–519. 32 indexed citations
15.
Ceccato, Filippo, Giorgia Antonelli, Anna Chiara Frigo, et al.. (2017). First-line screening tests for Cushing’s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS. Journal of Endocrinological Investigation. 40(7). 753–760. 39 indexed citations
16.
Cannavò, Salvatore, Soraya Puglisi, Placido Romeo, et al.. (2016). Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas. The Journal of Clinical Endocrinology & Metabolism. 101(4). 1872–1879. 28 indexed citations
17.
Rubin, Beatrice, Daniela Regazzo, Marco Redaelli, et al.. (2016). Investigation of N-cadherin/β-catenin expression in adrenocortical tumors. Tumor Biology. 37(10). 13545–13555. 14 indexed citations
18.
Mian, Caterina, Filippo Ceccato, Susi Barollo, et al.. (2014). AHR Over-Expression in Papillary Thyroid Carcinoma: Clinical and Molecular Assessments in a Series of Italian Acromegalic Patients with a Long-Term Follow-Up. PLoS ONE. 9(7). e101560–e101560. 26 indexed citations
19.
Occhi, Gianluca, Marco Losa, Nora Albiger, et al.. (2011). The Glucose-Dependent Insulinotropic Polypeptide Receptor is Overexpressed Amongst GNAS1 Mutation-Negative Somatotropinomas and Drives Growth Hormone (GH)-Promoter Activity in GH3 Cells. Journal of Neuroendocrinology. 23(7). 641–649. 35 indexed citations
20.
Regazzo, Daniela, Daniel Mollé, Gianfranco Gabai, et al.. (2010). The (193–209) 17‐residues peptide of bovine β‐casein is transported through Caco‐2 monolayer. Molecular Nutrition & Food Research. 54(10). 1428–1435. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lance Kates Breakdown of academic impact, for papers by Fabio Arturo Grieco Breakdown of academic impact, for papers by Luisa García-Haro Breakdown of academic impact, for papers by Jason S. Seidman Breakdown of academic impact, for papers by Samuel Wyllie Breakdown of academic impact, for papers by Manasvi S. Shah Breakdown of academic impact, for papers by Lijun Dai Breakdown of academic impact, for papers by A. Chevalier Breakdown of academic impact, for papers by R. Mark Meloche Breakdown of academic impact, for papers by Minglan Yang
Rankless by CCL
2026